SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by American Financial Advisors LLC

American Financial Advisors LLC trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 52,605 shares of the exchange traded fund’s stock after selling 3,193 shares during the period. SPDR S&P Biotech ETF accounts for 0.7% of American Financial Advisors LLC’s portfolio, making the stock its 29th biggest position. American Financial Advisors LLC owned approximately 0.07% of SPDR S&P Biotech ETF worth $5,197,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Kercheville Advisors LLC increased its holdings in shares of SPDR S&P Biotech ETF by 62.4% in the 3rd quarter. Kercheville Advisors LLC now owns 15,725 shares of the exchange traded fund’s stock worth $1,554,000 after acquiring an additional 6,045 shares during the period. Modera Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 14.5% in the 3rd quarter. Modera Wealth Management LLC now owns 23,489 shares of the exchange traded fund’s stock worth $2,321,000 after acquiring an additional 2,975 shares during the period. Wealth Enhancement Advisory Services LLC increased its holdings in shares of SPDR S&P Biotech ETF by 4.1% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 118,563 shares of the exchange traded fund’s stock worth $11,714,000 after acquiring an additional 4,625 shares during the period. Masso Torrence Wealth Management Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 0.9% in the 3rd quarter. Masso Torrence Wealth Management Inc. now owns 26,221 shares of the exchange traded fund’s stock worth $2,591,000 after acquiring an additional 228 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of SPDR S&P Biotech ETF by 16.3% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 21,390 shares of the exchange traded fund’s stock worth $2,113,000 after acquiring an additional 2,997 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock traded down $0.61 during trading hours on Tuesday, reaching $97.88. The stock had a trading volume of 2,651,943 shares, compared to its average volume of 9,358,792. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The firm has a 50-day simple moving average of $99.10 and a 200-day simple moving average of $94.70. The firm has a market capitalization of $7.46 billion, a PE ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.